Business
Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors
Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso’s Board Deborah Lafer Scher SAN
About this update from Ekso Bionics Holdings, Inc.
[{"type":"text","content":" Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso’s Board Deborah Lafer Scher SAN RAFAEL, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the appointment of Deborah Lafer Scher to its Board of Directors, effective June 6, 2024. “We are pleased to strengthen our Board with the addition of Deborah Lafer Scher, a distinguished leader who brings a wealth of healthcare experience and a proven track record of business development expertise,” said Scott Davis, President and Chief Executive Officer of Ekso Bionics. “Deborah’s advisory roles with the VA and the Milken Institute, combined with her extensive Board experience, make her a valuable addition to our Board. We look forward to the strategic value and unique insights that Deborah will bring to Ekso.” Ms. Scher brings extensive experience driving growth and building innovative healthcare organizations in both the public and private sector. As a former Executive Advisor to four Cabinet Secretaries across two Presidential administrations at the U.S. Department of Veterans Affairs, she led the VA Secretary’s Center for Strategic Partnerships and implemented more than $250 million in new programs benefitting veterans nationwide. Currently, she is a Senior Advisor at the Milken Institute, a healthcare and economic think tank. She also serves as an Independent Director on the Board at EnableComp, and as a Board Director at 2Serve Together. Ms. Scher has also held leadership positions at Weill Cornell Medical Center, Dun & Bradstreet, CareOne, Walsh International, and Warburg Pincus. Ms. Scher holds a Bachelor of Arts from Haverford College and a Master of Business Administration from Columbia University. “I am honored to join Ekso’s Board at a pivotal time for the Company, especially following the recent pricing determination for Medicare reimbursement of the Ekso Indego Personal,” said Ms. Scher. “Ekso’s differentiated technology has played a crucial role in rehabilitating thousands of patients, including many veterans. This commitment to improving patients’ lives is a key reason why I am pleased to join the Ekso Board and contribute to its mission.” About Ekso Bionics® E...